Intellipharmaceutics International Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Intellipharmaceutics International Inc.
Start-Up Spotlight: Jeremiah Robison Turns Cerebral Palsy ‘Passion Project’ Into Full-Time Commitment
The CEO of Cionic developed a garment used to analyze and augment human movement for people with stroke and cerebral palsy with plans to file for US FDA 510(k) clearance this fall.
The company says popular products like iPhones, iPads, AirPods and MacBook laptops contain magnets that could adversely affect the function of implantables, including pacemakers and defibrillators.
An expert panel at the recent AdvaMed Virtual Digital MedTech Conference discusses opportunities for medtech and consumer tech collaborations and how to make them successful.
The US FDA has granted de novo authorization to the Portable Neuromodulation Stimulator from Helius Medical Technologies. The PoNS device, previously given breakthrough status by the agency in May 2020, can improve the gait of patients with multiple sclerosis.
- Generic Drugs
- Controlled Release
- Other Names / Subsidiaries
- Vasogen, Inc.